Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPrevalence and predictors of insomnia in women with invasive ovarian cancer: Anxiety a major factor
European Journal of Cancer, 06/25/09
Price MA et al. - In a study to examine the prevalence and predictors of insomnia in a population-based sample of women with ovarian cancer, consistent with primary insomnia, elevated anxiety predicted insomnia in women with ovarian cancer. Given that both anxiety and insomnia are relatively common, and the relationship may potentially be bi-directional, the efficacy of interventions targeting insomnia and anxiety, rather than insomnia alone, is worthy of consideration.
Methods- Participants were 772 women participating in the Australian Ovarian Cancer Study – Quality of Life Study.
- Insomnia was assessed using the Insomnia Severity Index (ISI).
- Demographic, disease and treatment variables, and psychosocial variables, including anxiety and depression, support care needs and social support and coping, were investigated as potential predictors of insomnia.
- 27% of women reported sub-clinical symptoms of insomnia (ISI score 8–14) and 17% reported clinically significant insomnia (ISI score 15–28).
- 3 variables were significant predictors of clinically significant insomnia: young age (<50 yrs) relative to 70+ yrs; higher unmet needs in the physical/daily living domain and elevated anxiety.
- Women with cancer aged <60 yrs were more likely to report clinical levels of insomnia than women of 70+ yrs.
Related Articles
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 83%
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09
Relevance Score: 82%
Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer
BMC Cancer, 11/04/09
Relevance Score: 81%
Stage I breast cancer in a regional oncology practice in Israel 2002-2006: Clinicopathologic features, risk estimation and planned therapy of 328 consecutive patients
The Breast, 10/15/09
Relevance Score: 79%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 70%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk
Carcinogenesis, 12/15/09
The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication
American Journal of Medical Genetics, 12/15/09
Coexistent atypical polypoid adenomyoma and complex atypical endometrial hyperplasia in the uterus
Diagnostic Cytopathology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor